Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-06

Clinical Trial Update: Tb-PSMA-I&T Radionuclide Before Radical Prostatectomy in Patients With Locally Advanced Prostate Cancer - TbeforePROST Trial. [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes the Tb-PSMA-I&T radiopharmaceutical (TbeforePROST) trial for locally advanced/high-risk prostate cancer, currently in Phase…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tb-PSMA-I&T (Terbium-PSMA-I&T)

Snippet

Sponsor: Rabin Medical Center | Conditions: High Risk Prostate Cancer | Phase 1, Phase 2 | Status: RECRUITING